Showing results (131-140 of 253) with videos related to

Sort By:
Pageof 26
Blood|October 25, 2013
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHDAttilio Olivieri, Michele Cimminiello, Paolo Corradini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Functional Impact of Genomic Complexity on the Transcriptome of Multiple MyelomaBachisio Ziccheddu, Matteo C Da Vià, Marta Lionetti, et al.
British Journal of Haematology|May 11, 2012
Phase II study of sorafenib in patients with relapsed or refractory lymphomaAnna Guidetti, Carmelo Carlo-Stella, Silvia L Locatelli, et al.
European Journal of Haematology|March 3, 2007
Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myelomaBenedetto Bruno, Roberto Sorasio, Francesca Patriarca, et al.
Cancer|June 28, 2021
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma NetworkFrancesca Gay, Andreas Günther, Massimo Offidani, et al.
Hemasphere|October 7, 2022
Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple MyelomaPieter Sonneveld, Sonja Zweegman, Michele Cavo, et al.
Haematologica|October 15, 2020
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)Francesco Maura, Anna Dodero, Cristiana Carniti, et al.
Blood|August 20, 2013
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label studyAlessandra Larocca, Vittorio Montefusco, Sara Bringhen, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patientsAntonio Palumbo, Francesca Gay, Patrizia Falco, et al.
Pageof 26